NCT04859218View on ClinicalTrials.gov

Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Myelodysplastic Syndrome
Interventions
PROCEDURE

RBC transfusion

two consecutive transfusion episodes: an ABO identical product at one transfusion episode and an ABO non-identical product for the other episode. The number of RBCs given for each study transfusion episode will be identical 2 RBC units.

Trial Locations (1)

L8V-1C3

RECRUITING

Juravinski Hospital and Cancer Centre, Hamilton

All Listed Sponsors
collaborator

CBS

UNKNOWN

lead

McMaster University

OTHER